SAN DIEGO, CA / ACCESS Newswire / July 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical innovator focused on redefining opioid safety, ...

PORTLAND, Ore. (WKRC) - Firefighters revived a puppy with Narcan after a fentanyl overdose on Tuesday. According to the Lacey Fire Department District 3, firefighters discovered the puppy ...

The FDA is requiring manufacturers of opioid pain medications to update safety labels to better emphasize risks linked to their long-term use, the agency announced in a new Drug Safety Communication.

Findings from postmarketing studies showed long-term opioid use was associated with serious risks including misuse, addiction, and overdose. The Food and Drug Administration (FDA) is requiring ...

From 2021 to 2024, 59.0% of overdose deaths involved stimulants, according to research published in the Aug. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...

~ FDA and Ensysce Aligned on Collaborative Approach to Ensure Product's Full Safety Benefits are Recognized ~ PF614-MPAR has earned the FDA's prestigious Breakthrough Therapy designation and is ...